Tumor vasculature permeability (null)

Tumor vasculature permeability refers to the capacity of blood vessels within tumors to allow passage of molecules and cells across their walls. This is not a single molecular target but rather a physiological characteristic resulting from structural and functional abnormalities in tumor blood vessels. Compared with normal tissues, tumor vessels are typically more permeable ("leaky"), allowing easier extravasation of macromolecules—including nutrients, immune cells, and therapeutic agents—into the tumor microenvironment. This hyperpermeability is largely driven by factors secreted by tumor and stromal cells—most notably vascular endothelial growth factor A (VEGF-A). VEGF-A was originally identified as "vascular permeability factor" due to its potent ability to increase vessel leakiness. The abnormal structure and function of tumor vessels also contribute: they often lack proper smooth muscle coverage, have irregular branching patterns, thin walls with large fenestrations or gaps between endothelial cells, poor pericyte support, increased interstitial pressure inside the tumor mass—all leading to increased leakage compared with normal tissue vasculature. Therapeutic strategies do not directly target "tumor vasculature permeability" per se but aim either to normalize it—reducing excessive leakiness through antiangiogenic therapies targeting VEGF/VEGFR pathways—or transiently increase it for improved drug delivery using physical methods like radiation or pharmacologic agents that temporarily open up the endothelium. Drugs such as bevacizumab (anti-VEGF antibody) or ramucirumab (anti–VEGFR2 antibody) reduce both angiogenesis and vascular hyperpermeability by blocking these signaling pathways. Because "tumor vasculature permeability" is an emergent property rather than a discrete protein/receptor/enzyme/transporter/etc., it should not be considered a canonical therapeutic target on its own. Instead, it serves as an important parameter influencing cancer progression and response to therapy. "Tumor blood vessels are hyperpermeable... because most tumors generate new blood vessels by secreting VEGF-A... originally discovered as Vascular Permeability Factor." "The hyperpermeability... is presumably due to vascular endothelial growth factor/vascular permeability factor released by neoplastic... cells." "Vascular normalization... reduces excessive leakiness..."

Other names

Tumor vascular permeabilityTumor vessel permeabilityVascular hyperpermeability in tumors

null